Heartflow (HTFL) Cash from Financing Activities (2024 - 2025)
Heartflow (HTFL) posted Cash from Financing Activities of -$50000.0 for Q4 2025, down 100.02% on a QoQ basis from $214.9 million in Q3 2025, and down 105.88% year-over-year from $851000.0 in Q4 2024.
Powered by 
Analysis
Heartflow (HTFL) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Heartflow has reported Cash from Financing Activities for 2 years, with the latest figure at -$50000.0 in Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 105.88% year-over-year to -$50000.0 in Q4 2025; TTM through Dec 2025 was $216.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $286.0 million, up 12686.9% from the prior year.
- Cash from Financing Activities was -$50000.0 for Q4 2025 at Heartflow, down from $214.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $214.9 million in Q3 2025, with the low at -$50000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | -236.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 4.51 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -300,000.00 |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 3.95 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 200.60 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 880,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | -1.20 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -22.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | 214.94 Mn |
| Dec 31, 2024 | 851,000.00 |
| Sep 30, 2024 | 983,000.00 |